{"id":"W4404555543","doi":"10.1111/myc.70001","title":"The In Vitro Activity of Rezafungin Against Uncommon Species of <i>Candida</i>","year":2024,"lang":"en","type":"article","venue":"Mycoses","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Genentech; U.S. Food and Drug Administration; National Institutes of Health; Astellas Pharma; Basilea Pharmaceutica; TenNor Therapeutics; Carnegie Mellon University; Astellas Foundation for Research on Metabolic Disorders; Ohio State University; Nabriva Therapeutics; Pfizer; Melinta Therapeutics; Entasis Therapeutics; Wockhardt; Mundipharma International; Zoetis; Menarini Group; McGill University; Roche; Cidara Therapeutics; Medpace; Harvard University; Meiji Seika Pharma; Shionogi; National Cancer Institute; Gilead Sciences; GlaxoSmithKline; Dr. Falk Pharma","keywords":"Candida auris; Echinocandin; Broth microdilution; Fluconazole; Echinocandins; Microbiology; Candida dubliniensis; Biology; Minimum inhibitory concentration; Antifungal; Corpus albicans; Caspofungin; Antimicrobial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003251215,0.00007732298,0.0002454732,0.00005398209,0.00002662521,0.00000948151,0.00007231089,0.00004126473,0.00002049753],"category_scores_gemma":[0.0001868808,0.00004775045,0.0001009679,0.0002560661,0.0001511065,0.00004945589,0.00002965495,0.0001488205,0.000005780423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000052594,"about_ca_system_score_gemma":0.0001037693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001017958,"about_ca_topic_score_gemma":0.0002895826,"domain_scores_codex":[0.9992883,0.00003085357,0.0002059352,0.0001361176,0.0002017042,0.0001371211],"domain_scores_gemma":[0.9992272,0.0003943502,0.0000394783,0.0002730424,0.00003790931,0.00002805158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008054554,0.0001164453,0.04819055,0.0003937445,0.00003360528,0.00002717908,0.0002170763,0.000001815672,0.9246694,0.0004829932,0.001392007,0.02366965],"study_design_scores_gemma":[0.0002387373,0.0000979068,0.2325787,0.0003332112,0.00002515176,0.000001228856,0.0003402026,0.0001179405,0.7537,0.0002145561,0.01229369,0.00005867747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816704,0.003520436,0.00001628135,0.0004728051,0.0001081505,0.0001356666,0.00002583096,0.00001993111,0.01403045],"genre_scores_gemma":[0.9974158,0.0007642042,0.00003892774,0.00003780408,0.00004058894,0.000003757214,0.000004183869,0.000007908439,0.001686762],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1843881,"threshold_uncertainty_score":0.1947207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01588609272568805,"score_gpt":0.2744423396442611,"score_spread":0.2585562469185731,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}